POVIDONE K29/32
Unresolved Excipient
Suggest One
No specific molecular structure known for this excipient.
- CAS
- 9003398
- UNII
- 390RMW2PEQ
- SYNONYMS
-
- ZINC ID(s)
-
- Availability
- Present in 0 ZINC catalogs
Known Active Genes
There has not been any activity reported at 10μM or less for this excipient (per ChEBML)
Clinical Trials
This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).
(Browse) Purchasable Analogs in ZINC
Analogs cannot be located as there is no structure provided for this compound. Try a
search by name.
Dosages
| Route | Formulation | Per Unit Dose |
|---|---|---|
| Ophthalmic | Solution | 1.8% |
| Ophthalmic | Solution, Drops | 2% |
| Oral | Capsule | 15MG |
| Oral | Capsule, Coated, Soft Gelatin | 5MG |
| Oral | Capsule, Enteric Coated Pellets | 14.2MG |
| Oral | Capsule, Extended Release | 15MG |
| Oral | Capsule, Hard Gelatin | 10.5MG |
| Oral | Capsule, Sustained Action | 10.05MG |
| Oral | Granule | 6.7MG |
| Oral | Solution | 3.05% |
| Oral | Tablet | 62.2MG |
| Oral | Tablet (immed./comp. Release), Film Coated | 12.5MG |
| Oral | Tablet (immed./comp. Release), Uncoated, Chewable | 10MG |
| Oral | Tablet, Coated | 21MG |
| Oral | Tablet, Controlled Release | 20.5MG |
| Oral | Tablet, Delayed Action | 24MG |
| Oral | Tablet, Delayed Action, Enteric Coated | 13MG |
| Oral | Tablet, Enteric Coated Particles | 18.6MG |
| Oral | Tablet, Extended Release | 40MG |
| Oral | Tablet, Film Coated | 75MG |
| Oral | Tablet, Multilayer, Coated | 15MG |
| Oral | Tablet, Orally Disintegrating | 18MG |
| Oral | Tablet, Sustained Action | 45MG |
| Oral | Tablet, Sustained Action, Coated | 16MG |
| Oral-21 | Tablet | 4.5MG |
| Oral-28 | Tablet | 4.51MG |
| Oral-28 | Tablet, Coated | 4.51MG |
| Sublingual | Tablet | 8MG |
| Sublingual | Tablet (immed./comp. Release), Uncoated, Buccal | 8MG |
| Topical | Emulsion, Aerosol Foam | 1.9% |
| Transdermal | Film, Controlled Release | 7.27MG |
| Vaginal | Tablet | 50MG |